Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-30
2005-08-30
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S183000, C514S366000, C514S450000, C548S202000, C548S203000, C548S204000
Reexamination Certificate
active
06936628
ABSTRACT:
The invention relates to methods of increasing the bioavailability of orally administered epothilones. Epothilones administered by the methods of the invention are sufficiently bioavailable to have a pharmacological effect. The invention further relates to pharmaceutical compositions, pharmaceutical dosage forms, and kits for use in the methods of the invention.
REFERENCES:
patent: 6194181 (2001-02-01), Hofmann et al.
patent: 6204388 (2001-03-01), Danishefsky et al.
patent: 6211412 (2001-04-01), Georg et al.
patent: 6242469 (2001-06-01), Danishefsky et al.
patent: 6262094 (2001-07-01), Hoefle et al.
patent: 6316630 (2001-11-01), Danishefsky et al.
patent: 6365749 (2002-04-01), Kim et al.
patent: 6369234 (2002-04-01), Danishefsky et al.
patent: 6380227 (2002-04-01), Mutz
patent: 6380394 (2002-04-01), Nicolaou et al.
patent: 6518421 (2003-02-01), Li et al.
patent: 6576651 (2003-06-01), Bandyopadhyay et al.
patent: 6605599 (2003-08-01), Vite et al.
patent: 6686380 (2004-02-01), Lee
patent: 6727276 (2004-04-01), Lee
patent: 6780620 (2004-08-01), Li et al.
patent: 2003/0073677 (2003-04-01), Lee
patent: 2003/0187039 (2003-10-01), Favreau et al.
patent: 2003/0220295 (2003-11-01), Vite et al.
patent: 2004/0214871 (2004-10-01), Lee
patent: 4138042.8 (1993-05-01), None
patent: 19542986.9 (1997-05-01), None
patent: 19639456.2 (1997-05-01), None
patent: 19636343.8 (1998-03-01), None
patent: 19645361.5 (1998-04-01), None
patent: 19645362.3 (1998-04-01), None
patent: 19647580.5 (1998-05-01), None
patent: 19701758 (1998-07-01), None
patent: 19707505.3 (1998-09-01), None
patent: 19713970 (1998-10-01), None
patent: 19720312 (1998-11-01), None
patent: 19821954 (1998-11-01), None
patent: 19726627 (1998-12-01), None
patent: 879 605 (1998-11-01), None
patent: 93/10121 (1993-05-01), None
patent: 97/19086 (1997-05-01), None
patent: 98/08849 (1998-03-01), None
patent: 98/22461 (1998-05-01), None
patent: 98/24427 (1998-06-01), None
patent: 98/25929 (1998-06-01), None
patent: 98/38192 (1998-09-01), None
patent: 98/47891 (1998-10-01), None
patent: 99/01124 (1999-01-01), None
patent: 99/02514 (1999-01-01), None
patent: 99/03848 (1999-01-01), None
patent: 99/07692 (1999-02-01), None
patent: 99/27890 (1999-06-01), None
patent: 99/39694 (1999-08-01), None
patent: 99/42602 (1999-08-01), None
patent: 99/43320 (1999-09-01), None
patent: 99/43653 (1999-09-01), None
patent: 99/54319 (1999-10-01), None
patent: 99/67252 (1999-12-01), None
patent: 00/00485 (2000-01-01), None
patent: 00/31247 (2000-06-01), None
patent: 00/37473 (2000-06-01), None
patent: WO 00/039276 (2000-07-01), None
patent: 00/49021 (2000-08-01), None
patent: 00/66589 (2000-11-01), None
Balog, A. et al., Angew, Chem. Int. Engl. 35, No. 23-24, pp. 2801-2803, 1996.
Balog, A., et al., “Total Synthesis of (-)-Epothilone A”,Angew. Chem. Int. Ed. Engl.,vol. 35, No. 23/24, 2801-2803 (1996).
Bertini, F., et al., “Alkenes from Epoxides by Reductive Elimination with Magnesium Bromide-Magnesium Amalgam”,Chem. Commun.,144 (1970).
Bollag, D.M., et al., “Epothilones, A New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action”,Cancer Res.55, No. 11, 2325-2333 (1995).
Fujisawa, T., et al., “Deoxygenation of Epoxides to Olefins with FeCl3-n-BuLi System”,Chem. Lett.,883-886 (1974).
Fujiwara, Y., et al., “Reductive Coupling of Carbonyl Compounds to Olefins by Tungsten Hexachloride-Lithium Aluminum Hydride and Some Tungsten and Molybdenum Carbonyls”,J. Org. Chem.,vol. 43, No. 12, 2477-2479 (1978).
Gladysz, J. A., et al., “Deoxygenation of Epoxides by Metal Atom Cocondensation”,J. Org. Chem.,vol. 41, No. 22, 3647-3648 (1976).
Hofle, G., et al., “Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution”,Angew. Chem. Int. Ed. Engl.,vol. 35, No. 13/14, 1567-1569 (1996).
Hofle, G., et al., “N-Oxidation of Epothilone A-C and O-Acyl Rearrangement to C-19 and C-21 -Substituted Epothilones”,Angew. Chem. Int. Ed.,vol. 38, No. 13/14, 1971-1974 (1999).
Inokuchi, T., et al., “Opening of Epoxides to Olefins or Halohydrins with Vanadium(II)-Tetrahydrofuran or Vanadium(III)-Tetrahydrofuran Complexes”,Synlett,No. 6, 510-512 (1992).
Kowalski, R. J., et al., “Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)”J. Biol. Chem.,vol. 272, No. 4, 2534-2541 (1997).
Kupchan, S. M., et al., “Reductive Elimination of Epoxides to Olefins with Zinc-Copper Couple”,J. Org. Chem.,vol. 36, No. 9, 1187-1190 (1971).
Martin, M. G., et al., “Epoxides as Alkene Protecting Groups. A Mild and Efficient Deoxygenation”,Tetrahedron Letters,vol. 25, No. 3, 251-254 (1984).
McMurry, J. E., et al., “Reduction of Epoxides to Olefins with Low Valent Titanium”,J. Org. Chem.,vol. 40, No. 17, 2555-2556 (1975).
McMurry, J. E., et al., “Some Deoxygenation Reactions with Low-Valent Titanium (TiCl3/LiAIH4)”,J. Org. Chem.,vol. 43, No. 17, 3249-3254 (1978).
Meng, D., et al., “Remote Effects in Macrolide Formation Through Ring-Forming Olefin Metathesis: An Application to the Synthesis of Fully Active Epothilone Congeners”,J. Am. Chem. Soc.,vol. 119, No. 11, 2733-2734 (1997).
Nicolaou, K. C., et al., “An Approach to Epothilones Based on Olefin Metathesis”,Angew. Chem. Int. Ed. Engl.,vol. 35, No. 20, 2399-2401 (1996).
Nicolaou, K. C., et al., “Total Synthesis of Epothilone A: The Macrolactonization Approach”,Angew. Chem. Int. Ed. Engl.,vol. 36, No. 5, 525-527 (1997).
Nicolaou, K. C., et al., “Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, and Cytotoxic Action against Taxol-Resistant Tumor Cells”,Angew. Chem. Int. Ed. Engl.,vol. 36, No. 19, 2097-2103 (1997).
Nicolaou, K.C., et al., “The Olefin Metathesis Approach to Epothilone A and Its Analogues”,J. Am. Chem. Soc.,vol. 119, No. 34, 7960-7973 (1997).
Nicolaou, K. C., et al., “Total Syntheses of Epothilones A and B via a Macrolactonization-Based Strategy”,J. Am. Chem. Soc.,vol. 119, No. 34, 7974-7991 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase”,Nature,vol. 387, 268-272 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase” (Correction toNature387, 268-272 (1997),Nature,390, 100 (1997).
Raucher, S., et al., “Total Synthesis of (+)-Dihydrocostunolide via Tandem Cope-Claisen Rearrangement”,J. Org. Chem.,vol. 51, No. 26, 5503-5505 (1986).
Sato, M, et al., “Reduction of Organic Compounds with Low-Valent Niobium (NbCl5/NaAIH4)”,Chem. Letters,157-160 (1982).
Schinzer, D., et al., “Total Synthesis of (-)-Epothilone A”,Angew. Chem. Int. Ed. Engl.,vol. 36, No. 5, 523-524 (1997).
Schobert, R., et al., “Reduction and Isomerization of Oxiranes and α-Diazoketones by Various Early Transition Metallocenes”,Synlett,vol. 8, 465-466 (1990).
Sharpless, K. B., et al., “Lower Valent Tungsten Halides. A New Class of Reagents for Deoxygenation of Organic Molecules”,J. Amer. Chem. Soc.,vol. 94, No. 18, 6538-6540 (1972).
Su, D.-S., et al., “Total Synthesis of (-)-Epothilone B: An Extension of the Suzuki Coupling Method and Insights into Structure-Activity Relationships of the Epothilones”,Angew. Chem. Int Ed. Engl.,vol. 36, No. 7, 757-759 (1997).
Su, D.-S., et al., “Structure-Activity Relationships of the Epothilones and the First In Vivo Comparison with Paclitaxel”,Angew. Chem. Int. Ed. Engl.,vol. 36, No. 19, 2093-2096 (1997).
Victory, S. F., et al., “Relative Stereochemistry and Solution Conformation of the Novel Paclitaxel-Like Antimitotic Agent Epothilone A”,Bioorg. Med. Chem. Letts.,vol. 6., No. 7, 893-898 (1996).
Winkler, J. D., et al., “A Model For The Taxol (
Bristol--Myers Squibb Company
Greenblatt Gary D.
Jones Dwayne
Patel Rena
Winslow Anastasia P.
LandOfFree
Oral administration of epothilones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral administration of epothilones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral administration of epothilones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524109